Enforcement Report - Week of March 6, 2024
Annora`s Generic Mesalamine Receives Approval in the U.S.
AMTA' Generic Mesalamine Receives Approval in the U.S.
Encube's Generic Mesalamine Receives Receives Approval in the U.S.
Alembic Pharmaceuticals on Wednesday said it has received final approval from the US health regulator for its generic Mesalamine extended-release capsules indicated for the maintenance of remission of ulcerative colitis in adults.
Alembic's Generic Mesalamine Receives Approval in the U.S.
Sun Pharma yesterday announced that it has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for generic Mesalamine Extended Release Capsules, 500 mg, a company statement said.
Teva Pharmaceutical's Generic Ritonavir Receives Approval in the U.S.
Zydus Cadila has received final approval from the US Food and Drug Administration (FDA) to market mesalamine extended-release capsules in the strength of 0.375 g.
TEL AVIV & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of its 1000 mg strength generic version of Casana®1 (mesalamine) suppository medicine used to treat adults with active ulcerative proctitis (ulcerative rectal colitis), in the U.S.